Honestly? I can't advise on that. However, if they can show that the results were clearly wrong or swapped, then they could suggest a revise of the results based on their other patient data. This would be significant IMO.
As Vince said, the outcome is consistent across all dosages in both lesions. In both data sets.
The difference is the vehicle.
They really need to work out the EXACT reason....
- Forums
- ASX - By Stock
- BOT
- Ann: BTX 1503 Acne Phase 2 Study Results Presentation
Ann: BTX 1503 Acne Phase 2 Study Results Presentation, page-239
-
- There are more pages in this discussion • 412 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BOT (ASX) to my watchlist
(20min delay)
|
|||||
Last
38.0¢ |
Change
0.010(2.70%) |
Mkt cap ! $690.6M |
Open | High | Low | Value | Volume |
38.0¢ | 38.0¢ | 37.5¢ | $193.7K | 511.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
13 | 221953 | 37.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
38.0¢ | 242863 | 20 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
13 | 222283 | 0.375 |
26 | 460225 | 0.370 |
15 | 237790 | 0.365 |
13 | 210795 | 0.360 |
16 | 313757 | 0.355 |
Price($) | Vol. | No. |
---|---|---|
0.380 | 196362 | 17 |
0.385 | 368714 | 10 |
0.390 | 140242 | 9 |
0.395 | 260019 | 6 |
0.400 | 204827 | 7 |
Last trade - 12.04pm 10/10/2024 (20 minute delay) ? |
Featured News
LU7
The Breakdown: Lithium Universe talks refinery design and lithium processing in strong preliminary feasibility study for Bécancour
RCE
Phase II clinical trial recruitment for R327G topical gel passes halfway, showing promising results against bacterial skin infections
BOT (ASX) Chart |
The Watchlist
EL8
ELEVATE URANIUM LTD
Murray Hill, MD & CEO
Murray Hill
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online